Cells have been identified in postnatal tissues that, when isolated from multiple mesenchymal compartments, can be stimulated in vitro to give rise to cells that resemble mature mesenchymal phenotypes, such as odontoblasts, osteoblasts, adipocytes, and myoblasts. This has made these adult cells, collectively called mesenchymal stem cells (MSCs), strong candidates for fields such as tissue engineering and regenerative medicine. Based on evidence from in vivo genetic lineage-tracing studies, pericytes have been identified as a source of MSC precursors in vivo in multiple organs, in response to injury or during homeostasis. Questions of intense debate and interest in the field of tissue engineering and regenerative studies include the following: 1) Are all pericytes, irrespective of tissue of isolation, equal in their differentiation potential? 2) What are the mechanisms that regulate the differentiation of MSCs? To gain a better understanding of the latter, recent work has utilized ChIP-seq (chromatin immunoprecipitation followed by sequencing) to reconstruct histone landscapes. This indicated that for dental pulp pericytes, the odontoblast-specific gene Dspp was found in a transcriptionally permissive state, while in bone marrow pericytes, the osteoblast-specific gene Runx2 was primed for expression. RNA sequencing has also been utilized to further characterize the 2 pericyte populations, and results highlighted that dental pulp pericytes are already precommitted to an odontoblast fate based on enrichment analysis indicating overrepresentation of key odontogenic genes. Furthermore, ChIP-seq analysis of the polycomb repressive complex 1 component RING1B indicated that this complex is likely to be involved in inhibiting inappropriate differentiation, as it localized to a number of loci of key transcription factors that are needed for the induction of adipogenesis, chondrogenesis, or myogenesis. In this review, we highlight recent data elucidating molecular mechanisms that indicate that pericytes can be tissue-specific precommitted MSC precursors in vivo and that this precommitment is a major driving force behind MSC differentiation.
Introduction
Mesenchymal stem cells (MSCs) is the generic name (rightly or wrongly) commonly used to describe cells isolated from connective tissues (stroma) that, in vitro, exhibit properties of stem cells. The prototypical MSC, described almost 3 decades ago, resides within bone marrow (BM; Friedenstein et al. 1974; Caplan 1991; Pittenger et al. 1999) . Since then, cells with similar immunophenotype (in vivo and in vitro), molecular, and functional properties have been described in multiple organs, including teeth (Gronthos et al. 2000; Gronthos et al. 2002; Miura et al. 2003; Sonoyama et al. 2008) , dermis (Toma et al. 2001) , adipose (Zuk et al. 2002) , and muscle (Dellavalle et al. 2011) . Functional (in vitro) characteristics include their adherence to tissue culture plastic (Pittenger et al. 1999; Zhu et al. 2010) , morphologic similarity, multipotency, and trilineage differentiation into mesodermal lineages, including chondrocytes, adipocytes, and osteoblasts when stimulated with a cocktail of factors (Beltrami et al. 2007; Covas et al. 2008; Huang et al. 2009 ). While the field was intensely focused on studying and exploiting the in vitro characteristics of MSCs, much less attention was paid to identifying their in vivo origin, although certain observations have provided some important clues. To paraphrase Murray et al. (2014) , there has been great focus on multipotency and tissue engineering and repair, but the native origin and physiologic roles of MSCs in vivo have been greatly overlooked. The in vivo counterpart of cultureexpanded MSCs remained largely unknown for many tissues.
Connective tissues (stroma) exist throughout the body, and this suggests that their precursors are locally available in multiple tissues where they can act as a source of MSCs for homeostatic maintenance and repair of these structures. This would explain why MSCs can be isolated from almost all tissues (Bianco et al. 2001; Shi and Gronthos 2003; Farrington-Rock et al. 2004; Crisan, Huard, et al. 2008 ). In the late 1800s, a contractile cell population residing around capillaries was described by Charles Benjamin Rouget (1873). These Rouget cells were then renamed by Karl Zimmermann to what today we refer to as pericytes (Zimmermann 1923) , to better describe their perivascular location in close association with blood vessels. When we consider their cell surface marker profiles, pericytes express many MSC "markers" (in vivo and in vitro): CD90, CD73, CD105, and CD44. In addition, other markers-such as
1 Centre for Craniofacial and Regenerative Biology, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, UK CD146, α smooth muscle actin, neural glial antigen 2, and platelet-derived growth factor receptor β-have been associated with pericytes in multiple human and mouse organs, including pancreas, placenta, skeletal muscle, and adipose tissue (Caplan 2008; . Pericytes isolated with these markers can give rise to adipocyte-like, osteoblastlike, and chondrocyte-like cells in vitro through tailored tissue culture conditions (Doherty et al. 1998; Caplan 2008; Crisan, Huard, et al. 2008; Crisan et al. 2012 ). This has resulted in more similarities being identified between MSCs and pericytes (reviewed extensively by Caplan 2008; Feng et al. 2010 ), leading many researchers to an acceptance that in most tissues, pericytes are precursors of MSCs (Schwab and Gargett 2007; Covas et al. 2008) . A further source of evidence for this came from the observation that typical MSC cultures were capable of being established with blood vessels alone (Caplan 2007 ). Genetic lineage-tracing studies performed with a number of Cre-recombinase mouse lines are providing in vivo evidence showing that pericytes can give rise to mature MSC progenitors, such as odontoblasts (Feng et al. 2011) , osteoblasts (Supakul et al. 2019) , and myoblasts (Dellavalle et al. 2007 ; Fig. 1 ). A question that remains unanswered, however, is how a widely distributed differentiated cell type, a pericyte, can give rise to MSCs that will differentiate into tissue-specific cell types depending on the tissue where they are located. Is this a result of niche-originating signals or mechanisms more intrinsic that regulate the appropriate choice of cell fate (Feng et al. 2010 )?
Evidence of MSC Preprogramming
Although MSCs from many tissues can differentiate into osteoblast-like cells, chondrocyte-like cells, and adipocyte-like cells in vitro, they do not do this in vivo during homeostasis. Although a multipotent MSC may exist, no single cell has been definitively described that forms these 3 differentiated cell types in vivo. Several cell populations have been described that can undergo a form of multilineage differentiation ex vivo, but single-cell lineage tracing in vivo is needed to definitively prove the existence of a multipotent stem cell (Chan et al. 2018; Mizuhashi et al. 2018) .
Most MSCs when expanded in vitro show a certain homogeneity in their morphology, cell surface antigen profile, and differentiation potential when stimulated (Beltrami et al. 2007; Covas et al. 2008; Huang et al. 2009 ). It has, however, always been recognized that MSCs derived from a wide range of tissues are inherently different as suggested by in vitro experiments. Depending on where the cells are sourced from, they vary in their colony-forming efficiency (Peng et al. 2008) , their ability to influence the immune system (Hegyi et al. 2010) , and, most important, their potential to differentiate down certain mesodermal lineages. MSCs sourced from umbilical cord blood are unable to differentiate into adipocytes (Peng et al. 2008) or myoblasts (Sacchetti et al. 2016) . Conflicting reports exist with regard to adipose-derived MSCs and their ability to differentiate down osteogenic lineages (Covas et al. 2008; James, Zara, Zhang, et al. 2012; Azzaz et al. 2014) . It is likely that the outcomes of these experiments are context dependent on the adipose tissue depot used. What is clear from our observations and that from others, such as Sacchetti et al. (2016) , is that pericytes are most likely to yield cells appropriate to the tissue compartment from where they were isolated. It is important to note that the majority of experiments performed on MSCs describing their multipotency have been carried out with cells propagated in vitro. This could affect the behavior and innate plasticity of these cells. Therefore, more focus should be placed on studies where a strong emphasis is placed on observing these cells as close to their in vivo context as possible.
What we have observed is that mechanisms for faithful propagation of the appropriate lineage identity are established in these cells in vivo (Fig. 2) . To investigate these mechanisms, we isolated pericytes from mouse incisor and long bone. The selection of these cells was based on their proven ability to differentiate into 2 mineralized cell types (odontoblasts and osteoblasts, respectively) and their different embryonic derivation (cranial neural crest and pulp mesoderm, respectively; Dennis and Charbord 2002; Arthur et al. 2008) .
Isolated pericytes were profiled with a number of next-generation sequencing approaches, including RNA sequencing (RNA-seq) and chromatin immunoprecipitation followed by sequencing (ChIP-seq), to reveal extensive differences in the transcriptomes and histone landscapes of these cells (Yianni and Sharpe 2018) . What emerged was that fresh pericytes from tooth pulp and long BM shared expression of genes relating to Figure 1 . Pericyte injury/repair response in vivo. In response to injury or as part of maintaining tissue homeostasis, pericytes detach from the blood vessel wall and act as bona fide mesenchymal stem cells (MSCs), which we will refer to as pMSCs, to distinguish them from MSCs that are not pericyte derived. pMSCs can proliferate and move to the area of injury where they differentiate into tissue-specific cells to facilitate repair.
homeostatic processes and those involved in physical (adhesion) and molecular (signaling) interactions with the underlying vasculature. Epigenomic profiling revealed that the majority of genes in transcriptionally active chromatin regions, identified by the abundance for trimethylation of lysine 4 on histone 3 (H3K4me3; Dennis et al. 2003; Karlić et al. 2010; Zhang et al. 2015) , were shared between both pericyte populations and were statistically enriched for genes involved in regulation and maintenance of cell adhesion. The majority of the genes found in these H3K4me3 regions were confirmed to be actively expressed by RNA-seq profiling, this being a reflection of these pericytes' attachment to blood vessels. Focusing on gene expression differences between the 2 populations, a gene set enrichment analysis (Subramanian et al. 2005 ) unexpectedly revealed that dental pulp-residing pericytes were enriched for a number of genes involved in odontogenesis. The most striking feature in these incisor pericytes is a low baseline expression of Dspp, a gene expressed in odontoblasts, a highly specialized cell type that can differentiate from pericytes. This was also evident when the Dspp locus was interrogated for the prevalence of a transcriptionally permissive or repressive histone environment. Incisor pericytes possessed a sharp peak of H3K4me3 at the transcription start site of Dspp, while their BM counterparts did not. Mouse incisors grow rapidly (1.0 mm in 2 d; An et al. 2018) , and the transcriptionally open state of chromatin at the promoter of Dspp is indicative of a stem cell primed to differentiate. In the BM pericyte RNA-seq data sets, we did not detect significant expression of genes relating to osteoblast specification. However, when investigating the epigenetic landscapes of these BM pericytes, we found that the promoter of the Runx2 transcription factor, which is the master regulator and first step toward osteoblast differentiation (Gaur et al. 2005; James 2013 ), was in a bivalent state. This locus was abundant in both active and repressive histone posttranslational modifications, as shown by ChIP-seq (Yianni and Sharpe 2018; Fig. 3 ). This observation is intriguing, since it is known that bivalent promoters mark genes that are poised for activation should the cognate upstream regulator (e.g., a transcription factor) or stimulating signal become available (Dennis et al. 2003; Bernstein et al. 2006; Gan et al. 2007 ). This prompted further investigation into the epigenetic status of master regulators governing commitment for myogenesis, chondrogenesis, and adipogenesis. To do this, we performed a ChIP-seq experiment to identify the genomic binding sites for the catalytic subunit of polycomb repressor complex 1 (PRC1), RING1B. RING1B is an E3-ubiquitin ligase that allows PRC1 to polyubiquitinate lysine 119 of histones H2A (H2Aub119; Stock et al. 2007 ). This causes further compaction of that genomic locus and predominantly leads to stable repression of genes within that locus due to a number of reasons, including physical exclusion of transcription factors from subsequent binding (Ren et al. 2008; Vidal 2009; van Arensbergen et al. 2013) . What these data sets revealed was that a number of genes necessary to drive pericytes down inappropriate (for their organ) lineages were bound by RING1B and repressed. These included Myf5, Pax3, and Myod for myogenesis; Osr1, Runx3, Osr2, Nfib, Scx, and Sox9 for chondrogenesis; and Cebpa and Cebpb for adipogenesis. This highlighted that in vivo, BM and incisor pericytes are lineage restricted by previously undescribed mechanisms to give rise to preprogrammed MSCs that can then differentiate into organ-specific cell types. An important question this raises is, are these epigenetic mechanisms a by-product of niche-originating regulatory events, potentially driven by signaling cascades, or are these mechanisms innate in the pericytes themselves? To further investigate this, fluorescence-activated cell sorting (FACS)-isolated pericytes from both incisor pulp and BM were expanded in vitro with basal medium lacking any stimulating factors, thereby removing any potential niche-originating signals and tailored differentiation cocktails. Total RNA was collected from these cells after 31 d, and pericytes isolated from incisor pulp were found to have upregulated expression of Dspp, while pericytes isolated from BM had upregulated expression of Runx2, as compared with their fresh in vivo counterparts (Fig.  4) . These in vitro-expanded pericytes did not upregulate marker genes of any other mesodermal lineage. This observation indicates that although in vitro these pericytes can be driven to produce muscle, mineral, or fat, this is a by-product of their exogenous stimulation and not their endogenous lineage plasticity. These cells carry an epigenetic and transcriptomic program that persists even in culture that restricts them Figure 2 . Pericyte differentiation potential in vitro and in vivo. In vivo, pericytes have a tissue-specific epigenome and a transcriptome that is restricting their differentiation. Upon receiving a signal, these pericytes detach and adopt a mesenchymal stem cell (MSC) phenotype that is preprogrammed to give rise to cells that will facilitate repair. In vitro, isolated pericytes will adhere to tissue culture plastic and give rise to characteristic-looking MSC cultures. These can be directed to differentiate into any mesenchymal lineage with tailored stimulating factors that partially alter the inherent epigenetic/transcriptomic programs of these cells. As previously shown, if left unstimulated, these cells will upregulate lineage-specific genes of specialized cells appropriate to their tissue of residence (Yianni and Sharpe 2018) .
to a particular lineage-in this case, enforcing an odontoblast or an osteoblast differentiation program, respectively. This should not be surprising since ex vivo differentiation of BMand tooth pulp-derived MSCs clearly indicates tissue of origin-specific differentiation (Gronthos et al. 2000) . These data also accurately mirror the in vivo observations from lineagetracing studies showing the contribution of dental pericytes to odontoblasts (Feng et al. 2011; Vidovic et al. 2017) and BM pericytes to osteoblasts (Supakul et al. 2019) and not to other lineages within the same organ.
A recent study has led to some confusion regarding the role of pericytes as MSC precursors where lineage tracing with Tbx18, a gene reported to be expressed by pericytes, showed no evidence of a differentiated cell contribution in certain tissues, including fat, brain, and heart (Guimarães-Camboa et al. 2017) . In addition to already published comments on this study, our transcriptome data sets show no expression of Tbx18 in cells identified as pericytes (Yianni and Sharpe 2018) .
It is important to note that researchers outside the mineral biology field have also provided evidence indicating that in vivo, pericytes are not plastic but tissue-specific precommitted precursors of MSCs, although the molecular basis of this restriction was not investigated. In a recent study, Sacchetti and colleagues (2016) established MSC cultures from pericytes sourced from tissues including BM, skeletal muscle, and perinatal cord blood. These perivascular cells were FACS isolated from fresh human tissues with the criteria of being negative for pan-endothelial and pan-hematopoietic marker but positive for MCAM (CD34 − /CD45 − /CD146 + ). These cells gave rise to MSC colonies in vitro under basal culture conditions that do not stimulate differentiation. Using gene expression profiling, the authors determined the transcriptional signature of these cells and performed unsupervised hierarchical clustering and principal component analysis. An analysis of variance determined that these cells are radically divergent from each other in terms of the genes that they express when comparing the same "MSCs" isolated from different anatomic locations. They showed that the skeletal muscle cells express the lineage-specific myogenic transcription factor PAX7. Interestingly, BM MSCs express a number of genes associated with hematopoietic support, something that was also validated in our recent epigenetic studies. Sacchetti et al. (2016) noted that the pericytes that they prospectively isolated (CD34 A molecular method has been identified in dental and bone marrow pericytes that contributes to organ-specific lineage commitment before pericytes detach from the basal membrane of blood vessels. In incisor pericytes, a transcriptomically permissive chromatin structure is in place (high in H3K4me3) that allows transcription of Dspp to take place via the recruitment of RNA polymerase II (A). In contrast, while Runx2 is not expressed in bone marrow pericytes, we have identified that it is positioned in a bivalent chromatin environment that makes it amenable to transcription once the upstream cognate transcription factors become available (B). Fresh pericytes isolated from incisor and long bone will readily adhere to tissue culture plastic and give rise to conventional mesenchymal stem cell cultures. If they are left to proliferate and mature in the absence of stimulating factors, they will upregulate genes for the lineage specific to their tissue of origin (A). In contrast, most experiments perturb (or ignore) this innate mesenchymal stem cell differentiation bias. These cells are driven down nonspecific cell lineages by the addition of tailored supplements to give rise to mature, terminally differentiated mesenchymal derivatives (B).
natively skeletogenic but not myogenic, muscle-derived MSCs/pericytes are inherently myogenic but not natively skeletogenic and represent a subset of cells with functional features of satellite cells (Fig. 5) . Multiple studies independently corroborate that MSCs and their precursors, residing in a wide range of tissues, are very similar, but they are clearly not identical populations. It was first thought that the tissuespecific microenvironment could be a likely source of this variation, but evidence highlighted here would argue that this is something intrinsically encoded within the molecular memory of these cells. When we consider the differentiation capabilities of these cells (based on in vitro studies), it makes biological sense that molecular checkpoints would be in place to prevent nonspecific differentiation in vivo. It could be argued that with age these molecular mechanisms could be perturbed, as is suggested in tissues of aging patients or experimental animals where pericytes increasingly contribute to scarring and fibrosis as opposed to regeneration and repair (Sundberg et al. 1996; Göritz et al. 2011; Greenhalgh et al. 2013) .
Considerations for the Future
Recent publications in the field of MSC biology highlight a number of important concepts that have been largely overlooked or understudied. There is a widely shared acceptance that pericytes and MSCs are ubiquitous in the mesenchymal compartment of tissues and, regardless of the tissue they are sourced from, can be expanded to give a skeletogenic, adipogenic, or myogenic phenotypes depending on how they are stimulated. Data discussed here clearly demonstrate that these ubiquitous cells differ in their in vivo transcriptomes/epigenomes and are not uniform in terms of their lineage commitment: they represent subsets of tissue-specific lineagecommitted precursors.
A number of important points need to be raised; at this stage, it is unclear how differences in cell surface marker expression might possibly mirror functional heterogeneity in vivo. When we take into account the total pericyte content of a tissue, 1 subset of cells might be predestined to differentiate into mature mesodermal cells, while others are confined to functional properties relating to the maintenance of the underlying vasculature. Single-cell RNA-seq studies are being utilized to better understand the population architecture of pericytes within a given organ (He et al. 2018; Zeisel et al. 2018; Tikhonova et al. 2019 ). In the brain, for example, singlecell transcriptomics has identified 3 populations of pericytes (Zeisel et al. 2018) .
These studies can be used as a way to design lineage-tracing strategies to investigate the contribution of these subtypes to other cell types in vivo. Data discussed here have implications for a number of fields, including stem cell biology, regeneration, and also tissue engineering. In approaches that require the use of MSCs in a scaffold to facilitate repair in vivo, not all sources of primary cells will be equivalent in their ability to regenerate the tissue of interest.
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V. Yianni, P.T. Sharpe, contributed to conception, design, data acquisition, analysis, and interpretation, drafted and critically revised the manuscript. Both authors gave final approval and agree to be accountable for all aspects of the work. + ) from human bone marrow, postnatal umbilical cord blood, and skeletal muscle, which gave rise to traditional MSC cultures in vitro. These MSC cultures could differentiate only into bone-producing osteoblasts or hematopoietic-supporting stromal cells if they were derived from bone marrow (A). Umbilical cord blood MSCs could be differentiated only into chondrocytes (B) and skeletal muscle MSCs, only into myoblasts (C). Adapted from Sacchetti et al.
